期刊文献+

贝复济联合洁悠神治疗Ⅱ~Ⅲ期压疮的护理效果 被引量:3

The Effect of Combination of Recombinant Bovine Basic Fibroblast Growth Factor and JUC Long-acting Antimicrobial Material on the treatment of Stage Ⅱ or Ⅲ Bedsore
下载PDF
导出
摘要 目的探讨重组牛碱性成纤维细胞生长因子(贝复济)联合洁悠神治疗Ⅱ~Ⅲ期压疮的护理效果。方法将100例Ⅱ期、Ⅲ期压疮患者随机分为3组,贝复济组采用贝复济喷涂加无菌纱布包扎治疗,洁悠神组仅用洁悠神喷洒创面,不用包扎。实验组采用贝复济和洁悠神喷涂暴露治疗,观察治疗有效率和创面愈合时间。结果实验组的治愈率(66.7%)与贝复济组(20.0%)或洁悠神组(30.0%)比较均有显著性差异(P=0.000);实验组的愈合时间[(18.27±11.41)d]与贝复济组[(31.70±17.59)d]比较有显著性差异(P=0.044)。结论贝复济联合洁悠神治疗Ⅱ期、Ⅲ期压疮经济、方便、有效。 Objective To investigate the effect of recombinant bovine basic fibroblast growth factor(BGF) combined with JUC long-acting antimicrobial material in the treatment of stage Ⅱ or Ⅲ bedsore.Methods A total of 100 patients with stage II or III bedsore were randomly divided into three groups.BGF group was sprayed by BGF and sterile gauze bandaging therapy;JUC group was sprayed wound with JUC only,no dressing;BGF combined with JUC experimental group was sprayed with both BGF and JUC,no dressing.The treatment effecacy and wound healing time was observed.Results The cure rates of the experimental group,the BGF group,and the JUC group were 66.7%,20%,and 30.0% respectively.The difference among three groups was statistically significant(P=0.000).The difference of healing time between the experimental group[(18.27 ± 11.41) d]and the BGF group[(31.70 ± 17.59) d]was statistically significant(P=0.044).Conclusions It is economical,convenient and effective for JUC combined with BGF in the treatment of stageⅡ or Ⅲ bedsore.
出处 《健康教育与健康促进》 2015年第3期227-229,共3页 Health Education and Health Promotion
基金 上海医药高等专科学校教育科研基金项目(kt20120029) 上海市嘉定区卫生系统重点学科(ZD002)
关键词 压力性溃疡 洁悠神 碱性成纤维细胞生长因子 Pressure ulcer JUC Basic fibroblast growth factor
  • 相关文献

参考文献4

二级参考文献23

  • 1叶海云,侯树坤,曲星珂,王晓峰.细菌生物膜对尿管相关性尿路感染的影响[J].中华泌尿外科杂志,2006,27(2):135-138. 被引量:49
  • 2陈锋进.美沙酮维持疗法推广前景初探[J].浙江警察学院学报,2006,18(1):58-60. 被引量:4
  • 3李小寒,尚少梅.基础护理学.北京:人民卫生出版社,2008:83;86.
  • 4Pang L, HaoY, Mi G, et al. Effectiveness of first eightm ethadone ma- intenance treatment clinics in China [ J]. AIDS,2007,21 ( $ ) : 103 -107.
  • 5Prevention of hospital-acquired infections. A practical guide. 2nd edition 2002, WHO/CDS/CSR/EPH/2002.12.
  • 6Haley RW, Culver DH, White JW, et al. The nationwide noso- comial infection rate: a new need for vital statistics. AM J Epide- miol, 1985, 121: 159-167.
  • 7Trautner BW, Darouiche RO. Catheter associated infections: pathogenesis affects prevention. Arch Intern Med, 2004, 164: 842 -850.
  • 8Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis, 2001, 7 : 342-347.
  • 9Tambyah PA, Maki DG. Catheter-associated urinary tract infec- tion is rarely symptomatic: a prospective study of 1,497 catheter- ized patients. Arch Intern Med, 2000, 160: 678-682.
  • 10Sorbye LW, Finne-Soveri H, Ljunggren G, et al. Indwellingcatheter use in home care; elderly, aged 65 + , in 11 different countries in Europe. Age Ageing, 2005, 34: 377-381.

共引文献52

同被引文献28

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部